Status:
COMPLETED
Induction of Labor With Oxytocin: When Should Oxytocin be Held?
Lead Sponsor:
Lehigh Valley Hospital
Conditions:
Labor Induction
Cesarean Delivery
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
The investigators propose to perform a prospective randomized control trial to compare the rate of cesarean delivery in women where Oxytocin (OT) is discontinued once active labor begins (5 cm dilatio...
Detailed Description
Oxytocin is the most common agent used to induce and augment labor. Oxytocin injection is approved by the Food and Drug Administration for the initiation or improvement of uterine contractions to achi...
Eligibility Criteria
Inclusion
- Candidates for the study are pregnant women (with one fetus) scheduled for induction of labor with oxytocin at term gestation or greater, regardless of the indication for induction, bishop score (cervical dilation) or parity.
Exclusion
- Exclusions include women with multiple gestations, previous cesarean sections, and documented fetal anomalies.
- Women with contraindications to labor or induction will also be excluded.
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
252 Patients enrolled
Trial Details
Trial ID
NCT00957593
Start Date
February 1 2009
End Date
August 1 2011
Last Update
April 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lehigh Valley Health Network
Allentown, Pennsylvania, United States, 18105